TenX Keane Acquisition extends business combination deadline to August 18, 2024 via $66,667 note from Citius Pharma

CITIUS ONCOLOGY, INC.

Citius Pharma deposited $66,667 into trust to extend deadline from July 18 to August 18, 2024; fourth monthly extension.
Prior extensions occurred on April 26, May 17, and June 17, 2024; Company can extend up to November 18, 2024.
Promissory note is unsecured, bears no interest, and is repayable only upon closing if trust balance >= $2M.
Extension funded under Merger Agreement; Note is evidenced by Exhibit 10.4 to this 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.